Engelman, Kathleen
- University of Massachusetts Medical School · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #2,740
- Sustained Excellence
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2018 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$2.4M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#2,740
By linked amount among FY2023 PIs
Earliest Year Loaded
2018
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Engelman, Kathleen as a PI. Multi-PI records show the full award amount for context.
- 5U24AI126683-08U24Contact PINonhuman Primate Reagent ResourceUniversity of Massachusetts Medical School · Internal Medicine (NIH department code)$1.8Maward amount
- 5P40OD028116-04P40Contact PINonhuman Primate Antibody Resource for Immune Cell DepletionUniversity of Massachusetts Medical School · Internal Medicine (NIH department code)$621Kaward amount
Award organization
Organizations that administered FY2023 awards listing Engelman, Kathleen as a PI.
FY2023 award administered by University of Massachusetts Medical School (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2018First NIH AwardUniversity of Massachusetts Medical School
- 2018$500K Cumulative Funding
- 2018$1M Cumulative Funding
- 2018$2M Cumulative Funding
- 2018Entered Top 50% NationallyRanked #2028
- 2018Entered Top 25% NationallyRanked #2028
- 2019$5M Cumulative Funding
- 2019Entered Top 10% NationallyRanked #1749
- 2020Entered Top 5% NationallyRanked #670
- 2021$10M Cumulative Funding